The Things to Think About Before Taking Your Biotech Company Public

▤ Summary

The article outlines what biotech companies should prepare before going public as the IPO window reopens in 2026. It highlights the importance of securing supportive investors early, building long-term relationships, and understanding which backers will participate in a public-market transition. It also stresses the need for the right CFO, audited financials, and enough lead time to complete IPO preparation. The piece notes that companies often keep IPO, M&A, and collaboration options open at the same time because timing and deal structure can materially affect the path forward.

▦ Linked Companies